Trevena Inc (TRVN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

955 CHESTERBROOK BOULEVARD CHESTERBROOK, PA 19087

Trevena, Inc. develops pharmaceutical products. The company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, acute chronic pain, and depression. Trevena serves customers throughout the United States.

Data based on most recent fiscal year report
Market Cap95.319 Million Shares Outstanding62.3 Million Avg Volume1.238 Million
1-Yr BETA vs S&P TR Current Ratio3.71 Quick Ratio3.71
View SEC Filings from TRVN instead.
Q1 2019 All Institutions Hedge Funds 1
To trade TRVN now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 54 9 (0.92%)
Aggregate 13F shares on 03/31/2019: 21.779 Million 6.595 Million
Aggregate 13F shares on 12/31/2018: 19.934 Million 3.283 Million
Percent change: 9.25% 100.87%
Funds creating new positions: 9 2
Funds Adding to an existing position: 11 1
Funds closing out their position: 11 2
Funds reducing their position: 14 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TRVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

7.5 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KOPPEL ADAM

  • Director
  • 10% Owner
0 2019-06-20 0

NADER FRANCOIS

  • Director
0 2019-06-19 0

NUNN JASON RALEIGH

6,000 2019-06-12 1

GOWEN MAXINE

15,000 2019-06-06 2

MCHUGH JULIE

  • Director
109,337 2019-06-05 1

DOUGHERTY MICHAEL R

  • Director
0 2019-06-04 1

BOURDOW CARRIE L. PRESIDENT AND CEO

  • Officer
  • Director
286,698 2019-06-03 4

DEMITRACK MARK SR VP & CHIEF MEDICAL OFFICER

  • Officer
116,020 2019-06-03 2

YODER ROBERT T SR. VP, CHIEF BUSINESS OFFICER

  • Officer
93,128 2019-06-03 3

HAMILL JOHN P. VP FIN,PRINC FIN&ACCT OFFICER

  • Officer
82,234 2019-05-31 3

BRAUNSTEIN SCOTT

  • Director
5,019 2019-05-29 3

YANNI BARBARA

  • Director
0 2019-05-16 1

MOULDER LEON O JR

  • Director
0 2019-05-16 2

PHILLIPS ANNE M.

  • Director
8,680 2019-05-16 1

CUCA ROBERTO CFO

47,575 2019-05-10 0

LIMONGELLI JOHN M SVP & GENERAL COUNSEL

  • Officer
0 2019-03-20 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

CHAMPSI FARAH

JANNEY DANIEL

NOHRA GUY P

  • Director
  • 10% Owner
No longer subject to file 2018-10-01 0

HABIB YACOUB SVP, BUS DEV & CORP PLANNING

  • Officer
0 2018-03-22 0

VIOLIN JONATHAN SVP-SCIENTIFIC AFFAIRS & IR

  • Officer
0 2018-02-28 0

GEOGHEGAN DAVID SR. VP, OPERATIONS

  • Officer
0 2018-02-28 0

LARK MICHAEL W. SR. VP, RESEARCH & CSO

  • Officer
0 2017-08-28 0

SOERGEL DAVID SR. VP,CLINICAL DEV. & CMO

  • Officer
0 2017-03-02 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRETT M JAMES

BARRIS PETER J

BASKETT FOREST

DRANT RYAN D

KERINS PATRICK J

KOLLURI KRISHNA KITTU

SANDELL SCOTT D

  • 10% Owner
5,619,734 2014-12-12 0

DEEGAN ROSAMOND SR VP, BUS DEV & OPERATIONS

  • Officer
31,105 2014-09-29 0

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

MCGUIRE TERRANCE

FLINT JONATHAN A

  • 10% Owner
3,769,280 2014-08-14 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

YODER ROBERT T - Officer SR. VP, CHIEF BUSINESS OFFICER

2019-06-03 F 6,872 $1.17 d 93,128 93,128.00 direct

DEMITRACK MARK - Officer SR VP & CHIEF MEDICAL OFFICER

2019-06-03 F 8,980 $1.17 d 116,020 116,020.00 direct

HAMILL JOHN P. - Officer VP FIN,PRINC FIN&ACCT OFFICER

2019-06-03 F 5,516 $1.17 d 82,234 82,234.00 direct

BOURDOW CARRIE L. - Director - Officer PRESIDENT AND CEO

2019-06-03 F 17,802 $1.17 d 286,698 286,698.00 direct

HAMILL JOHN P. - Officer VP FIN,PRINC FIN&ACCT OFFICER

2019-05-31 P 7,500 $1.16 a 87,750 82,234.00 direct

YANNI BARBARA - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

DOUGHERTY MICHAEL R - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

MOULDER LEON O JR - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

BRAUNSTEIN SCOTT - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

GOWEN MAXINE - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

PHILLIPS ANNE M. - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

NUNN JASON RALEIGH - Director

2019-05-16 A 30,000 a 30,000 0.00 direct

MCHUGH JULIE - Director

2019-05-16 A 30,000 a 30,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments